Company Overview of Visterra, Inc.
Key Executives for Visterra, Inc.
|Brian J. G. Pereira M.D.||20 Relationships||Chief Executive Officer, President and Director||57|
|Alan L. Crane M.A., M.B.A.||84 Relationships||Founder, Chairman of The Board, Chairman of Compensation Committee and Member of Audit Committee||53|
|Ram Sasisekharan Ph.D.||48 Relationships||Founder and Director||51|
|David A. Arkowitz||5 Relationships||Chief Financial Officer and Chief Operating Officer||55|
Visterra, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Alan L. Crane M.A., M.B.A.||84 Relationships||Cerulean Pharma Inc.||53|
|Brian J. G. Pereira M.D.||20 Relationships||Visterra, Inc.||57|
|Ram Sasisekharan Ph.D.||48 Relationships||Cerulean Pharma Inc.||51|
|Edwin M. Kania Jr.||96 Relationships||Flagship Pioneering||58|
|Akshay K. Vaishnaw M.D., Ph.D.||35 Relationships||Alnylam Pharmaceuticals, Inc.||53|
Visterra, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee Jr.||Edwin M. Kania||96 Relationships||3 Executives|
|Compensation Committee M.A., M.B.A.||Alan L. Crane||84 Relationships||4 Executives|
|Nominating Committee M.D., Ph.D.||Akshay K. Vaishnaw||35 Relationships||2 Executives|
|Corporate Governance Committee M.D., Ph.D.||Akshay K. Vaishnaw||35 Relationships||2 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$516.0K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.